Poussot to take over as Wyeth CEO

Share this article:

Wyeth will promote its No. 2 executive, Bernard Poussot, to CEO effective Jan.1 under a planned succession, the drugmaker said.

Poussot will succeed current CEO Robert Essner, who will become non-executive chairman of the board during a transition period beginning in the new year.

Poussot has served as Wyeth's president and vice chairman since April 2006. In January he added the role of chief operating officer.

Essner has worked at Wyeth since 1989 and has been CEO since May 2001.
 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.